SNDX vs. MTSR, KYMR, IMVT, MOR, CRNX, ALVO, HCM, AMRX, CPRX, and BHC
Should you be buying Syndax Pharmaceuticals stock or one of its competitors? The main competitors of Syndax Pharmaceuticals include Metsera (MTSR), Kymera Therapeutics (KYMR), Immunovant (IMVT), MorphoSys (MOR), Crinetics Pharmaceuticals (CRNX), Alvotech (ALVO), HUTCHMED (HCM), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), and Bausch Health Cos (BHC). These companies are all part of the "pharmaceutical products" industry.
Syndax Pharmaceuticals vs. Its Competitors
Syndax Pharmaceuticals (NASDAQ:SNDX) and Metsera (NASDAQ:MTSR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.
Syndax Pharmaceuticals currently has a consensus price target of $34.10, indicating a potential upside of 261.42%. Metsera has a consensus price target of $55.00, indicating a potential upside of 32.31%. Given Syndax Pharmaceuticals' higher possible upside, equities analysts clearly believe Syndax Pharmaceuticals is more favorable than Metsera.
Metsera has a net margin of 0.00% compared to Syndax Pharmaceuticals' net margin of -757.53%. Metsera's return on equity of 0.00% beat Syndax Pharmaceuticals' return on equity.
In the previous week, Syndax Pharmaceuticals had 4 more articles in the media than Metsera. MarketBeat recorded 8 mentions for Syndax Pharmaceuticals and 4 mentions for Metsera. Metsera's average media sentiment score of 0.76 beat Syndax Pharmaceuticals' score of 0.36 indicating that Metsera is being referred to more favorably in the news media.
Metsera has lower revenue, but higher earnings than Syndax Pharmaceuticals.
Summary
Metsera beats Syndax Pharmaceuticals on 6 of the 10 factors compared between the two stocks.
Get Syndax Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SNDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Syndax Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:SNDX) was last updated on 7/17/2025 by MarketBeat.com Staff
Free SNDX Stock Alerts